Business, Education and Schools, Free News Articles, Funding and Investment

BioBuilder funded to expand student opportunity in rural and urban areas through its collaborative after school program

BOSTON, Mass. -- Thanks to a two-year grant recently awarded by BioMADE, the BioBuilder Educational Foundation will expand a program that has supported thousands of high school inventors over the last decade. BioBuilder is leading the project, "Launching High School Bioengineers on their Paths to College and Careers," with funding that will bring the authentic tools and approaches for engineering biology to BioBuilderClub students nationwide in collaboration with East Tennessee State University, Ars Biotechnica, and Daicel Arbor Biosciences.

Support from BioMADE will enable these organizations to provide teams of young innovators new opportunities to design, build and test their biodesigns, and submit their research for publication as peer-reviewed manuscripts in BioTreks (Ars Biotechnica). Industry-standard biomanufacturing reagents and mentorship from professional scientists will be provided by Daicel Arbor, while East Tennessee State University will expand the geographic and demographic reach of the BioBuilderClub and spearhead a rigorous evaluation of its impact.

Thomas Tubon, Chief Workforce Development Officer for BioMADE said, "With the bioeconomy expected to contribute over a million jobs in this field by 2030, and the growing desire to connect local feedstocks to nearby manufacturing capabilities, a program like this is essential as it can raise awareness and provide opportunities to students, regardless of geography or demography."

Founder and Executive Director of BioBuilder, Dr. Natalie Kuldell shared that, "We are thrilled to be building momentum in non-traditional STEM hubs. By simultaneously training students and celebrating their achievements, this work will draw students into the exciting and creative sides of science and engineering. It will also increase awareness among community stakeholders, including parents of participating students, high school teachers, college admissions officers, and relevant local businesses."

These goals are fully aligned with the recently signed Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy that establishes the National Biotechnology and Biomanufacturing Initiative. The National Biotechnology and Biomanufacturing Initiative will create jobs, leverage biotechnology to build more resilient supply chains, improve health outcomes, and lower prices for Americans by expanding biomanufacturing capacity, creating market pathways for bio-based products, training a diverse workforce, and fostering innovation.

About BioBuilder:

Created by an award-winning team from MIT, BioBuilder empowers teachers and schools to better serve students and employers by elevating the skills that students are taught. Founded in 2011, BioBuilder has grown to partner with schools in almost every state and around the world. BioBuilder builds confidence in teachers to learn and apply the synthetic biology curricula, and provides laboratory kits and an openly accessible textbook that enable experiential learning.

BioBuilder also works directly with district and community leaders to identify potential roadblocks to narrow the gap between science innovation and science education -- at least for biology - across the U.S., and better match the skill of our nation's workforce to the needs of the synthetic biology industry. Learn more by visiting https://biobuilder.org/.

About BioMADE:

Launched in 2021, BioMADE is a Manufacturing Innovation Institute sponsored by the U.S. Department of Defense. By supporting the development of biomanufacturing technologies, BioMADE and its network of 150+ members across 29 states are strengthening American competitiveness, creating a more resilient supply chain, and helping the U.S. becoming more self-sufficient. Learn more about BioMADE by visiting https://www.biomade.org/.

About ETSU:

East Tennessee State University (ETSU) is a public research university in Johnson City, Tennessee. It is the fourth largest university in the state with nearby off-campus centers. It hosts the James H. Quillen College of Medicine, often ranked as one of the top schools in the United States for rural medicine and primary care education; the Bill Gatton College of Pharmacy, the College of Nursing, the College of Public Health, and the recently formed College of Clinical and Rehabilitative Health Sciences. Learn more about ETSU at https://www.etsu.edu/.

About Ars Biotechnica:

Ars Biotechnica is a public nonprofit corporation with the goal of teaching high school students and teachers about synthetic biology. They publish BioTreks, the first international synthetic biology journal to be authored and reviewed by high school students. The journal is intended to give participating students the valuable experiences of writing and evaluating scientific papers, while offering them opportunities to share their own synthetic biology ideas, techniques, and results in a professionally edited, online publication. Learn more by visiting https://biotreks.org/.

About Daicel Arbor Biosciences:

Daicel Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a biotech company that is specialized in targeted Next Generation Sequencing (NGS), in situ hybridization probe design, and cell-free protein expression. Their products and services have been utilized in broad applications in genomics, cytogenetics, and synthetic biology. They have served customers in plant, animal, human, bacteria, and virus areas for more than fifteen years. Learn more by visiting https://arborbiosci.com/.

Related link: https://biobuilder.org/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Funding and Investment, General Editorial

BabyLiveAdvice Announces $1.1M Seed Investment to Improve Maternal-Infant Health Outcomes

CALABASAS, Calif. -- BabyLiveAdvice™, the leading virtual maternal telehealth provider, announced the completion of a $1.1 million seed investment led by Venn Ventures and Synergen Technology Labs. BabyLiveAdvice, founded by CEO Sigi Marmorstein, RN, PHN, MSN, FNP-BC, partners with healthcare providers and health systems to support coordinated, comprehensive prenatal, postpartum, and infant care anywhere by closing the care gaps experienced by expecting and new parents. The result is reduced complications and better outcomes for parents and babies.

Participating strategic investors span the healthcare ecosystem, including

* Venn Ventures, venture capital group,

* Synergen Technology Labs, technology innovators,

* Ob Hospitalist Group (OBHG) the nation's largest and only dedicated OB hospitalist provider,

* CareFirst BCBS, payer organization, and

* LifeBridge Health, hospital system.

"Providing safe and timely care to pregnant people and infants has always been a tremendous challenge," said Marmorstein. "Now, with decreasing outpatient and inpatient care capacities, related to provider burnout and shortage, maternal-infant care gaps are growing, resulting in worsening outcomes for parents and babies.

"BabyLiveAdvice's unique approach enables it to reduce these gaps and improve outcomes to enhance, not replace, the current standard of care."

BabyLiveAdvice had served over 40,000 parents, including Hispanic, Black, Navajo Nation, and other historically underserved populations. Through research and pilots, BabyLiveAdvice has demonstrated improved clinical outcomes, decreased emergency room use, reduced readmissions, and fewer postpartum complications.

Marmorstein explained how BabyLiveAdvice, "provides services that support marginalized, remote communities at a fraction of the cost with improved outcomes. We are the only company on the market that can support the entire pregnancy journey in one place from the comfort of the user's home without increasing the provider burden. With BabyLiveAdvice, babies now come with instructions."

Users have access to a network of resources and support for their journey to parenthood, including nurses, nurse-practitioners, doulas, lactation specialists, socialworkers, mental health providers, nutritional specialists, care coordinators, diabetic specialists, and virtual group education classes.

BLA provides users with virtual, live maternal education classes that support self-care and self-advocacy. Users receive significantly improved maternal-infant education in lactation, proper nutrition, mental health, weight management, blood pressure and blood sugar control, and other benefits.

"Maternal health is often overlooked and is an area of healthcare ripe for innovation benefitting both parents and children," said Melissa Larson Youngblood, BabyLiveAdvice Board Member and Co-Founder and Partner at Venn Ventures, which co-led the investment round. "It was easy to invest in BabyLiveAdvice and Sigi as a women entrepreneur. The company is mature, has a strong pipeline, and has tens of thousands of users across the nation."

BabyLiveAdvice leverages a VSee-built, customized telehealth solution that is HIPAA-compliant, featuring EHR integration, telemonitoring capabilities, chat functionality, and group or one-on-one consultations. All consultations are documented, and notes are shared with the patient's medical provider through seamless EHR integration to assure medical and supportive care are well aligned.

"Through our BabyLiveAdvice partnership, we look forward to providing new maternal care resources to our patients and hospital partners," said Dr. Amy VanBlaricom, OBHG's Chief Clinical Officer and BabyLiveAdvice board member. "We are especially excited about BabyLiveAdvice's potential to positively impact patients with access to care challenges and the minority populations we serve. BabyLiveAdvice aligns with OBHG's mission of saving the lives of mothers and babies regardless of location, race, or economic status. Supporting patients throughout all phases of pregnancy, including the prenatal and postpartum stages, is so important in closing gaps in care."

BabyLiveAdvice partners include March of Dimes, Johnson and Johnson, The National Black Doulas Association, LifeBridge Health Sinai Hospital in Baltimore, Huntington Health, AltaMed, among others.

For media queries and BLA partnerships contact David Marmorstein: david@babyliveadvice.com.

About BabyLiveAdvice:

BabyLiveAdvice is a woman and nurse-founded company with the mission to close the care gaps in maternal childcare and reduce maternal and infant morbidity and mortality around the world. BabyLiveAdvice has helped tens of thousands of parents to get one-on-one support and education from a caring provider in their language. Its mission is to help parents and improve the statistics surrounding pregnancy, births, and maternal wellbeing.

Learn more: https://babyliveadvice.com/

RELATED LINKS:

https://vsee.com/

https://vennventures.com/

https://www.synergentl.com/

Related link: https://www.babyliveadvice.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Funding and Investment

Proteios Technology, Inc. Awarded $1.6 Million NIH SBIR Grant to Commercialize its Multivariate Cell Isolation Technology

SEATTLE, Wash. -- Proteios Technology, Inc. is pleased to announce it's received a $1.6 million SBIR Phase II grant from the National Institutes of Health (NIH) to commercialize its multivariate (parallel) cell isolation technology. Grant funds will be used to extend Proteios' cell isolation kits to include up to 20 of the most common cell types currently used in cell therapy development.

Cell biology is complex. And conducting experiments on an isolated population of cells, rather than a heterogeneous mix, is a common approach to reduce experimental complexity. Cell isolation allows cell biologists to confidently attribute observed effects and responses to a particular cell type.

Specifically, Proteios' multivariate cell isolation technology provides high-performance, antibody- and magnetic bead-free isolation of cell types in fewer than 30 minutes. This is a big reduction in time compared to currently available methods, while meeting or exceeding cell yield, purity and viability.

Proprietary Proteios Chimeras will be designed and developed to bind to each of the 20 target cell types with high specificity and selectivity through a combination of robotic biological screening, Machine Learning (ML) and Molecular Dynamics (MD) simulation.

Proteios will also incorporate Proteios Chimeras into its cGMP cell therapy manufacturing device - a bench prototype funded under contract by the National Cancer Institute (NCI). The device provides end-to-end manufacturing of cell therapies in a closed and fully-automated system with concise control over the multiple cell types that form the basis of cell therapy formulations. Proteios Chimeras will be a major component of consumables for the cGMP cell therapy manufacturing device.

"It's believed that the effectiveness of cellular therapeutics can be improved by the addition/removal of certain secondary cell types," Bob Snyder, Ph.D., co-founder and CEO of Proteios Technology, says. "Proteios' cell isolation technology will provide for the parallel enrichment and/or depletion of any cell type as new cell therapy formulations are investigated, reducing the vein-to-vein time and overall manufacturing cost."

Proteios is also preparing for the immediate commercial release of its research-scale recombinant protein purification kits which will provide a viable alternative to His Tag technology, unusable with about 20 percent of proteins of interest.

Initially, Proteios will launch two kits based on a proprietary affinity tag and a silica-based resin for:

1 - high-expressing proteins; and

2 - low-expressing proteins.

To learn more: https://www.proteios.com/

About Proteios Technology:

Proteios Technology is a leading provider of products and services dedicated to supporting the discovery of advanced therapeutics and their efficient manufacturing. Its innovative solutions support research at all levels from discovery and translational research to cGMP manufacturing and companion diagnostics. Its technologies enable the multivariate (parallel), tag-free isolation of any biological, including proteins/biopharmaceuticals, cell types, antibodies and viruses. Proteios' research-scale kits enable the discovery of new advanced therapeutics. And the inherent scalability of the technology allows the same methodology to be used in the manufacturing of advanced therapeutics and dramatically reduces the time required for process development.

Proteios is driven by the goal to lower the cost of healthcare and to provide advanced therapeutics to a larger patient population. It's located in the heart of Seattle and adjacent to some of the world's leading cell therapy research institutes - including the Fred Hutchinson Cancer Research Center, Seattle Children's Research Institute and the Seattle Cancer Care Alliance.

Related link: https://www.proteios.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Funding and Investment

TMC Emerging Technology Fund LP Invests in Willow Servicing

SAN DIEGO, Calif. -- The Mortgage Collaborative (TMC), the nation's largest independent cooperative network serving the mortgage industry, announced today that the TMC Emerging Technology Fund LP (the "Fund") recently participated in a $6 million seed round for Willow Servicing. The round was led by Thomvest Ventures, with participation from Global Asset Capital, Webb Investment Network and Zigg Capital.

Willow Servicing was founded in 2021 with the vision of modernizing the core technology that orchestrates the collection of $18 trillion of U.S. mortgage debt. Willow's cloud-based mortgage servicing platform automates routine servicing tasks and compliance, allowing small and large servicers to efficiently service loans in-house.

"Partnering with TMC gives us direct access to a broad network of lenders who can provide guidance on the changing dynamics within the mortgage industry and invaluable feedback on our product roadmap and offering," said Laura Cain, CEO of Willow Servicing. "We are eager to continue building out our platform and automate the most error-prone and difficult tasks facing mortgage lenders and servicers. The additional funding will allow us to continue investing in our customers and solving their pain points."

Since launching its platform in Q1 2022, Willow has serviced over $750 million in loans. While initially designed to manage interim servicing, Willow has quickly expanded to support additional loan types and processes, from HELOCs and construction loans to appraisal fees and payoffs.

Feliks Viner, vice president of secondary markets at First World Mortgage and Tech Fund council member, said, "Willow Servicing's platform has been a perfect solution for our interim servicing needs. The entire process, from initial onboarding to managing daily workflow, has been seamless with real-time support and a user-friendly website. Willow has allowed us to effortlessly automate our interim servicing process and provide our customers with timely notifications and simple payment options. We are thrilled for our continued partnership with Willow Servicing."

The Limited Partners of the TMC Emerging Technology Fund consist of some of the most technology-forward lender members of TMC who evaluate and invest in companies looking to advance the mortgage industry. The Fund continues to look for investment opportunities that will result in higher profitability and business process improvement for TMC lender members. For more information, please reach out to tmctechfund@mtgcoop.com. To learn more about Willow Servicing, visit https://www.willowservicing.com/ or reach out at sales@willowservicing.com.

About The Mortgage Collaborative

Based in San Diego, Calif., The Mortgage Collaborative was founded in 2013 by four notable industry leaders and is the nation's largest independent mortgage cooperative network. TMC is singularly focused on creating an environment of collaboration and innovation for small to mid-size mortgage lenders across the country to reduce cost, increase profitability, and better serve the dynamic and changing consumer base in America. For more information, visit http://www.mortgagecollaborative.com/

Related link: https://www.mortgagecollaborative.com

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Funding and Investment, Insurance

New Energy Risk Announces Milestone as Clients Raise $3B in Capital, Also Announce Senior Promotions

AVON, Conn. -- New Energy Risk (NER), a wholly-owned division of Paragon Insurance Group, on June 30 surpassed $3 billion in capital raised by clients since inception, a pivotal marker as the company continues to support the deployment of innovative technology solutions to address climate change and other global challenges.

Learn more about this achievement in NER's announcement, https://newenergyrisk.com/clients-surpass-3-billion/, and more about some of NER's clients via its case studies, https://newenergyrisk.com/case-studies/.

"This $3 billion milestone demonstrates the success of our products and underscores our commitment to 'Underwriting a Greener Future,'" NER Chief Executive Officer Tom Dickson said. "We are at the forefront of providing insurance solutions to the innovators who are accelerating the green energy transition. The capital they raise is an indication of rapidly increasing investor demand for positive impact."

Building on this momentum, NER is announcing that Chief Actuary Sherry Huang, a seven-year veteran of the company, is expanding her role to also support transaction approval and execution as chief actuary and managing director of underwriting development. Brad Price is being promoted from principal engineer to managing director of technical due diligence. Brentan Alexander has stepped down as president of NER and will be joining an emerging technology firm in the coming weeks. He has been a key leader in the success of NER since joining in 2012 and will remain involved as a consultant to NER for an extended period of time.

"Congratulations to the NER team and to Brad and Sherry on their additional responsibilities and to Brentan on his new endeavor," said Andy Borst, Paragon's president of E&S and International. "The $3 billion in capital raised is a major achievement that confirms NER as a leader in providing innovative solutions and underscores Paragon's commitment to investing in and supporting businesses that help address climate change and other global challenges."

About New Energy Risk:

New Energy Risk is a pioneer of large-scale, breakthrough technology performance insurance solutions. The company provides complex risk assessment and serves as a bridge between technology innovators, financiers, and insurers. Insurance policies are administered through New Energy Risk affiliate Complex Risk and Insurance Associates, LLC, CA License #0I24307. Visit: https://newenergyrisk.com/.

About Paragon:

Paragon Insurance Holdings, LLC, formed in 2014, writes all commercial lines of insurance across more than 20 programs. Paragon's industry-specific and general underwriting facilities offer insureds, retail agents, carriers, reinsurers and service providers unique product, service, capability, and results. Visit: https://www.paragoninsgroup.com/.

Related link: https://www.paragoninsgroup.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Education and Schools, Free News Articles, Funding and Investment, Regional Events

COVERGENCE – the research institution tech and startup gap fund and startup accelerator summit

SALT LAKE CITY, Utah -- COVERGENCE, co-hosted by innovosource and the University of Utah's PIVOT Center, is in its fifth annual year. This year it will be held from Oct. 20-21 at the University of Utah Rice-Eccles Stadium Club. With more than 60 university gap fund/accelerator programs (GAP) and potential commercial and investment partners, this dynamic event will serve as the platform for best practice discussions, GAP program and portfolio reviews, and commercial and investment partnering.

For more than 17 years, Jacob Johnson, innovosource founder, has worked to bridge the gap between researchers, investors and corporations. He's launched initiatives and supported programs like gap funds and accelerator programs (GAP), that advance promising research institution technology and startups from the lab to corporate collaboration and outside investment.

Seventy percent of COVERGENCE participants represent leaders of research institution-managed proof of concept, startup accelerator, and venture gap fund programs with the remainder of representatives coming from corporate innovation and venture firms.

"COVERGENCE brings all these important entities together in one place," Johnson says. "There are multiple opportunities to learn from and share with fellow GAP program leaders, and showcase your portfolio and opportunities to potential commercial and investment partners."

Research institutions will get to experience direct relationship building with other executive GAP program leaders and portfolio managers, leveraging $88 B+ in research funding per year. They'll also get to meet with corporate innovation teams and investors who can help to bridge university gap funding (proof of concept, startup, venture), or what is often to referred to as the "valley of death."

What exactly is the valley of death? It's the gap between the lab research and the marketplace where early-stage capital and technology/startup development support is lacking. This "gap" extends from where funding of basic research ends to where existing technology-driven companies or investors are willing to accept the risk to commercialize or invest in the technology or startup. The negative result is that a large portion of economic creation and commercial potential is left unrealized.

This shortage of early-stage development capital and support is a serious threat to future innovation and associated societal benefits. So, to address this challenge, research institutions and partners have led in the creation of technology and startup gap funding and accelerator support programs as a capital and innovation support mechanism. These programs are uniquely positioned to address critical elements of technology development and startup formation from research institutions.

innovosource's most recent landscape report reveals that 176 gap-fund and accelerator programs from 97 universities included in our GAP community have:

* invested $665MM of their internal funds into more than 1,500 startups and 1,000 corporate-licensed technologies;

* realized $8B+ in direct follow-on investment from corporations, investors, and public funds

* originated 90 percent of opportunities from institutions outside of Boston, New York, and Silicon Valley; and

* supported a diverse portfolio of applications in biopharma and medical devices, software and apps and food, agriculture and energy.

From partner panels and investor focus groups to happy hour mixers and fund/accelerator program and portfolio briefs this event is designed to be exclusively intimate, capping registrants at 150.

COVERGENCE is designed to be an intimate event that helps to maximize relationship building and knowledge exchange. Attendees will have ample time to meet each other and provide a basis to carry those relationships forward long after the Summit ends. There's a huge opportunity for collaboration and partnership to help university-founded startups scale their programs and tech/startup assets.

Some past participants said:

* "COVERGENCE was a great conference to learn more about the complexities of gap funding at universities, from grants to venture. Great topics, networking, and even a little bit of fun thrown in."

* "This was a great opportunity for a small program like ours to compare notes with more established, larger programs to compare best practices."

* "COVERGENCE was worth the intercontinental travel. With a high concentration of experts, entrepreneurs and investors, it really was an eye-opening experience."

And, the benefits to COVERGENCE research institutions can actually start before the Summit begins. How? Research Institutions can apply to provide a GAP program/portfolio brief at the Summit and more broadly submit to COVERGENCE GAP opportunity platform for review and feedback from corporate/investor participants before, during, and after event.

At the event, university participants will receive core GAP best practice discussions, as well as corporate/investor/and innovation ecosystem panels. Limited opportunity also exists for institutions to join a side-track to provide GAP program and portfolio reviews to participating corporations and investors.

Cost for research institutions to attend COVERGENCE 2022 is $399 and that includes registration and access to the pre-event partnering site and submission to the opportunity database. For more information and to register, visit: https://www.innovosource.com/covergence-2022.

About innovosource:

Over the past 15 years, innovosource (https://www.innovosource.com/) has worked with and supported hundreds of gap funding programs around the world. By partnering with research institutions and affiliates, innovosource informs, connects, and advocates for technology and startup gap funding and accelerator support programs.

Related link: https://www.innovosource.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Education and Schools, Free News Articles, Funding and Investment, Regional Events

innovosource summit to connect early-stage investors with university-managed tech and startup funds and accelerator programs

MINNEAPOLIS, Minn. -- innovosource will host its fifth annual COVERGENCE Summit from Oct. 20-21, 2022, at the University of Utah Rice-Eccles Stadium Club. The event gathers more than 60 university gap fund/accelerator programs (GAP) and potential commercial and investment partners to discuss best practices and review portfolios and investable projects and startups.

Jacob Johnson, innovosource founder, works to bridge the gap between researchers, investors and corporations and says that there is a real opportunity to address the lack of early-stage capital and innovation development support through strong university GAP fund and investor partnerships

"These summits serve as the meeting place to introduce investors to GAP program leaders and their pipelines of promising technologies and startups. By aligning with these programs, investors will see high-potential opportunities that have already gone through significant de-risking and validation. They are at the place where they are seeking investment and commercial partners to take the technologies and startups to market," he says.

Interested investors will benefit in multiple ways. They'll gain inside access to a wide array of investable tech/startups coming out of these gap-fund and accelerator programs and will get to experience direct relationship building with executive program leaders and portfolio managers, leveraging $88 B+ in research funding per year. Investors will also gain insights into emerging technology advances and themes while learning how to finesse early-stage investment strategies for programs that produce a high-rate of investable and ready-to-commercialize technologies and startups.

Universities and hospitals are leading through the implementation of university gap funding (proof of concept, startup, venture) and accelerator programs to bridge this "valley of death." Over the past 15 years, these programs have evolved into sophisticated investment, evaluation, development, and commercialization support mechanisms to nurture the most promising opportunities in emerging, high-growth technology areas.

Smart companies and investors are taking notice and making it a strategic, external innovation priority to partner with these gap fund and accelerator programs through applied research, proof of concept projects, seed and venture investments, and advisory/mentorship in return for insights, competitive positioning, and access to future technology and startups.

innovource's most recent landscape report reveals that 176 gap-fund and accelerator programs from 97 universities have:

* invested $665MM of their internal funds into more than 1,500 startups and 1,000 corporate-licensed technologies;

* realized $8B+ in direct follow-on investment from PE, family offices, and angels

* originated 90 percent of opportunities from institutions outside of Boston, New York, and Silicon Valley; and

* supported a diverse portfolio of applications in biopharma and medical devices, software and apps and food, agriculture and energy.

From partner panels and investor focus groups to happy hour mixers and fund/accelerator program and portfolio briefs this event is designed to be exclusively intimate, capping registrants at 150.

"We keep events intimate to maximize relationship building and knowledge exchange. Attendees will have ample time to meet each other and provide a basis to carry those relationships forward long after COVERGENCE," Johnson says.

A former attendee said, "COVERGENCE offers insight into a niche industry that the corporate and investment worlds are neglecting. There is a huge opportunity for collaboration and partnership to help university-founded startups scale their businesses."

Cost for investors to attend COVERGENCE 2022 is $499 that includes registration and access to the pre-event partnering site and opportunity database.

For more information and to register, visit: https://www.innovosource.com/covergence-2022 .

About innovosource:

Over the past 15 years, innovosource (https://www.innovosource.com/) has worked with and supported hundreds of gap funding programs around the world. By partnering with research institutions and affiliates, innovosource informs, connects, and advocates for technology and startup gap funding and accelerator support programs.

Related link: https://www.innovosource.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Funding and Investment

Nutrition Company PlantBaby Raises $4 Million Seed Round with Big Idea Ventures and The Fund LA, Among Others

KAUAI, Hawaii -- PlantBaby, the innovative nutrition company developing a portfolio of the purest plant-based products to support the nutritional journey from infancy into adulthood, announces its $4 million Seed funding round, led by Big Idea Ventures and The Fund LA.

The round also welcomed new institutional investors including Two Culture Cap, Springbank Collective, Western Technology Investment, and Niche Capital.

In December 2021, PlantBaby launched its first product Kiki Milk, the first organic plant-based milk designed specifically for kids. Kiki Milk is made with a blend of organic, whole foods and boosted with nourishing superfoods available in two flavors: Original and Chocolate formulated in partnership with leading pediatrician Dr. Joel "Gator" Warsh and nutritionist Vicki Kobliner, RD.

It is made only from nutrient-rich, plant-based, organic whole foods and contains no additives like refined sugars, gums, GMOs, glyphosate, preservatives, protein isolates, or tree nuts (except coconuts). The organic, whole foods utilized to create Kiki Milk include organic oats, organic hemp seeds, organic sprouted pumpkin seeds, and organic coconuts. Each variation is packed with its proprietary blend of superfood powders with nourishing plants, like organic Aquamin(tm), organic bananas, organic blueberries, and organic spinach.

For PlantBaby Co-Founders Lauren and Alex Abelin, this is the first step to realizing their vision of creating safe plant-based food options for kids. Six months after their son Alakai was born, they needed to find him suitable plant-based, soy-free, and dairy-free infant formula supplements. After researching and feeling dissatisfied with the options available, they sought to create products to suit his needs along with the 40% of kids who have chronic health conditions nationwide who need healthier solutions than the ones offered on the market already.

"Since launching just six months ago, we've seen constant consumer demand," said Co-Founder Alex Abelin. "This fundraising round will support continued research and development of new plant-based culinary innovations and continued growth of the brand to make PlantBaby itself a vehicle to create positive change for children's health and well-being of children everywhere."

"We are thrilled to support the great work being done by Lauren, Alex, and the rest of the PlantBaby team," said Tom Mastrobuoni, Chief Investment Officer for Big Idea Ventures. "The non-dairy space is highly competitive, but the PlantBaby team has created a unique product that features cleaner label ingredients and appeals to the most precious consumers of all, our children."

About PlantBaby:

PlantBaby is a future-forward nutrition movement developing a portfolio of clean-label, organic, plant-based foods, beverages, formulas, and supplements to support children on their nutritional journey from infancy into adulthood. Founded in 2020 on Kauai, Hawaii, PlantBaby is dedicated to restoring harmony in our food and agricultural systems by supporting regenerative agriculture and sourcing climate-friendly crops. PlantBaby is proud to partner with Farmer's Footprint and Planet FWD, two organizations committed to building a healthier Planet Earth.

For additional information, visit https://www.plantbaby.co/, https://www.kikimilk.com/ and @kikimilkco.

About Big Idea Ventures:

Big Idea Ventures (BIV), the most active food technology investor in 2021, is solving the world's greatest challenges by supporting the world's best entrepreneurs, scientists and engineers. BIV develops the most globally strategic funds, delivering significant investor returns while addressing real world challenges. BIV is focused on alternative protein with its New Protein Fund and commercialization of university intellectual property with its Generation Food Rural Partners fund. Learn more: https://bigideaventures.com/.

Related link: https://www.plantbaby.co/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Advertising and Marketing, Business, Free News Articles, Funding and Investment, Software

TMC Emerging Technology Fund LP Invests in leadPops

SAN DIEGO, Calif. -- The Mortgage Collaborative (TMC), the nation's largest independent cooperative network serving the mortgage industry, announced today that the TMC Emerging Technology Fund LP (the "Fund") recently participated in a follow-on round to a recent $3.5M Series A completed by leadPops, a digital customer acquisition software and marketing innovation platform. leadPops allows users to create robust, automated lead-generating systems that drive qualified leads directly to their business. Current leadPops clients leverage tools such as lead funnels, lead-generation websites and in-house managed marketing services to drive and secure high-quality leads with solid conversion potential.

"At leadPops, we believe driving traffic and clicks doesn't matter if you're not converting those clicks into clients, which is why we're thrilled to partner with The Mortgage Collaborative at a time when many mortgage companies need us the most" said CEO and Co-Founder of leadPops Andrew Pawlak. "The TMC Tech Fund's investment will help further accelerate leadPop's growth while allowing us to positively impact the more than 250 mortgage companies that are part of TMC. It's a big win for everyone involved, and the leadPops team is ready to rock."

leadPops was founded in 2011 to help mortgage, real estate and insurance businesses thrive online through optimized conversion. Existing partnerships include the Association of Independent Mortgage Experts (AIME), C2 Financial, Fairway Independent Mortgage, Movement Mortgage, Thrive Mortgage and many more. With more than 3,000 clients nationwide, leadPops was named one of the country's fastest-growing companies in 2021, earning it a place on the Inc. 5,000 list.

"Andrew literally wrote the book on mortgage lead generation and has a profound amount of knowledge and experience in lead generation and management for mortgage, real estate and insurance professionals," said Sandy Selman, Venture Partner for the TMC Emerging Technology Fund. "Andrew has boundless enthusiasm to help his clients succeed and is among that rare breed of entrepreneur in whom we are fortunate to invest."

The Limited Partners of the TMC Emerging Technology Fund consist of some of the most technology-forward lender members of TMC and are responsible for evaluating and investing in companies looking to advance the mortgage industry to the next level. The Fund continues to look for investment opportunities that will result in higher profitability and business process improvement for TMC lender members. For more information, contact info@tmctechfund.com. To learn more about leadPops, visit https://leadpops.com.

About The Mortgage Collaborative:

Based in San Diego, CA., The Mortgage Collaborative was founded in 2013 by four notable industry leaders and is the nation's largest independent mortgage cooperative network. TMC is singularly focused on creating an environment of collaboration and innovation for small to mid-size mortgage lenders across the country to reduce cost, increase profitability, and better serve America's dynamic and changing consumer base. For more information, visit http://www.mortgagecollaborative.com/

Related link: https://www.mortgagecollaborative.com

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Funding and Investment

AI Radiology and Emerging Medical Technology Venture Capital Investment Group Now Open to Outside Participation

LOS ANGELES, Calif. -- Seventeen-year-old ProNova Partners has been contracted to facilitate the expansion of an Artificial Intelligence Radiology Imaging and emerging Medical Technology Venture Capital Investment Group.

"This venture capital investment partnership was founded in 2018," announced Rick Carlson, CEO of ProNova Partners. "On behalf of their members, they find and invest in game changing, cutting edge, emerging companies specializing in Artificial Intelligence Radiology Imaging and other Medical Technologies."

"The group is owned and operated by three managing partners with broad ranging domain expertise," continued Carlson. "We are very pleased to work with such a qualified group. They are finding and investing at the early stages in firms at the razor's edge of Artificial Intelligence in medical technology." Carlson's company has assisted the expansion or sale of some 400 companies in a wide variety of market segments.

"The investment group has already seen high quality, sector specific deal flow, and boasts of a robust current portfolio of investments in leading edge technologies," concluded Carlson.

"The investment firm's distinguished Managing Partners' combined credentials span venture capital investment expertise. This includes domain expertise in radiology covering a broad range of aspects of radiology and MRI imaging, entrepreneurship, artificial intelligence, and other emerging medical technologies. Their combined knowledge and experience establish them as ideally suited to spearhead the formation of a selected group of physician and non-physician investors plus providing groundbreaking leadership in early stage company investments in the AI/Imaging/Radiology sector."

For detailed information go to: https://pronovapartners.com/engagement/ai-radiology-and-emerging-technology-firm-for-sale/

Related link: https://www.pronovapartners.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022